Pure Global
NCT06412094

Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis

A Comparative Controlled Study of the Effectiveness of Using a Mobile Application in Managing Pediatric Atopic Dermatitis
Avanta Trading Ltd.·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Atopic Dermatitis
Drug/Device/Intervention
Standard care
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Avanta Trading Ltd.
Location
Samara, Russian Federation
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2022
End date
Dec 26, 2022
Enrollment
66 participants
Primary outcome

Patient Oriented Eczema Measure (POEM),SCORAD (SCORing Atopic Dermatitis)

Summary

A randomized controlled study in children with AD, divided into three groups: a control group
 without access to the app, an experimental observational group with the app, and an
 experimental interventional group with potential investigator supervision. Outcome measures
 included the SCORAD and the POEM scores.

ICD-10 classifications
Atopic dermatitisAtopic dermatitis, unspecifiedOther atopic dermatitisAcute atopic conjunctivitisAllergic contact dermatitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06412094
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06412094 through Pure Global AI's free database. This phase not specified trial is sponsored by Avanta Trading Ltd. and is currently Completed. The study focuses on Atopic Dermatitis. Target enrollment is 66 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.